跳至主要内容
临床试验/NCT03474926
NCT03474926Unknown2 期

Prospective Randomized Phase II Trial: Comparing the Prognostic Value of Routine Lymphadenectomy Versus Lymphadenectomy Only for Lymph Nodes Enlargement Found in Preoperative Imaging or During Surgery Undergoing Nephroureterectomy in Patients With Primary Upper Tract Urothelial Carcinoma

RenJi Hospital2 个研究点 分布在 1 个国家目标入组 504 人开始时间: 2018年2月22日最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
504
试验地点
2
主要终点
Disease free survival

研究概览

简要总结

Recent studies showed the therapeutic benefit of lymphadenectomy in advanced stage urothelial carcinoma of the upper urinary tract, but there is still a lack of prospective studies. Thus, the current guideline recommends lymph node dissection for invasive upper tract urothelial carcinoma (UTUC) on the basis of insufficient evidence. Also, the preoperative judgment of muscle invasive pathological stage T 2+,or N+ is difficult from preoperative imaging. In the investigators' clinical practice, the surgeons performed dissection of regional lymph nodes only in patients with enlargement of lymph nodes found in preoperative imaging or during surgery. The aim of this multi-institutional study was to examine the role of lymphadenectomy in urothelial carcinoma of the upper urinary tract.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
15 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •clinically diagnosed with upper tract urothelial carcinoma
  • •have no distant metastasis
  • •have an Eastern Cooperative Oncology Group (ECOG) score 0 to 2
  • •expected to receive radical nephroureterectomy

排除标准

  • •a prior history of bladder cancer
  • •administration of neoadjuvant chemotherapy
  • •deny to receive long term follow-up
  • •patients with contralateral UTUCs
  • •patients with synchronous muscle invasive bladder cancer

研究组 & 干预措施

Routine lymph node dissection (LND) during nephroureterectomy

Experimental

Template-based LND was carried out in all patients in this group. The anatomical extent of LND is described in previous study. Lymph node specimens were sampled "en bloc" with surrounding adipose tissue, and were sent to pathological examination as individual packets with the surrounding adipose tissue.

干预措施: Routine Template-based lymphadenectomy (Procedure)

LND for lymph nodes enlargement found before or during surgery

Active Comparator

LND was carried out only in patients who have lymph nodes enlargement in preoperative imaging (CTU or enhanced MRI) or who were found lymph nodes enlargement during surgery.

干预措施: LND only for lymph nodes enlargement found in preoperative image or during surgery (Procedure)

结局指标

主要结局

Disease free survival

时间窗: 36 month

Disease free survival rate in the 36 month following nephroureterectomy

次要结局

  • Cancer specific survival(36 month)
  • Overall survival(36 month)
  • The recurrence rate of bladder cancer in the 36 month following nephroureterectomy(36 month)
  • Perioperative complications rate(90 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验